EIDD-1931
EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV) [1].
Product Specifications
CAS Number
3258-02-4
Product Name Alternative
β-D-N4-hydroxycytidine; NHC
UNSPSC
12352005
Hazard Statement
H228, H315, H319
Target
CHIKV; Enterovirus; HCV; SARS-CoV; Topoisomerase
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
Neuroscience-Neuromodulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/beta-d-n4-hydroxycytidine.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 25 mg/mL
Smiles
O=C(N/1)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=CC1=N/O
Molecular Formula
C9H13N3O6
Molecular Weight
259.22
Precautions
H228, H315, H319
References & Citations
4
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
AMPK alpha-1 Monoclonal Antibody, AbBy Fluor™ 350 Conjugated